Inventor · disambiguated record
Yizhou Dong
Also filed as: DONG YIZHOU
22 granted patents·15 pending applications·274 citations·filing 2009–2023
95Inventor score
Files withOHIO STATE INNOVATION FOUNDATION19MASSACHUSETTS INST TECHNOLOGY10TRANSLATE BIO INC5LEE KUO-HSIUNG1SHIRE HUMAN GENETIC THERAPIES1
Top patents by PatentIndex Score
37 records- 0198US10086013B2Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Oct 2, 2018·76 cites·34 claims
- 0297US10682374B2Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Jun 16, 2020·14 cites·16 claims
- 0397US9629804B2Lipid formulations for delivery of messenger RNASHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Apr 25, 2017·60 cites·18 claims
- 0497US9512073B2Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2012·Granted Dec 6, 2016·54 cites·33 claims
- 0596US10959953B2Lipid formulations for delivery of messenger RNATRANSLATE BIO INC·Filed 2019·Granted Mar 30, 2021·10 cites·24 claims
- 0696US10052284B2Lipid formulations for delivery of messenger RNATRANSLATE BIO INC·Filed 2017·Granted Aug 21, 2018·20 cites·9 claims
- 0794US9315472B21,3,5-triazinane-2,4,6-trione derivatives and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Apr 19, 2016·23 cites·25 claims
- 0890US10493031B2Lipid formulations for delivery of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Dec 3, 2019·7 cites·13 claims
- 0988US11890377B2Lipid formulations for delivery of messenger RNATRANSLATE BIO INC·Filed 2021·Granted Feb 6, 2024·1 cites·20 claims
- 1086US2024293319A1Lipid Formulations for Delivery of Messenger RNATRANSLATE BIO INC·Filed 2023·Application pending·0 cites
- 1185US11458158B2Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Oct 4, 2022·1 cites·20 claims
- 1285US10369122B2Benzene-1,3,5-tricarboxamide derivatives and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2016·Granted Aug 6, 2019·2 cites·21 claims
- 1384US12065667B2Modified Cpf1 MRNA, modified guide RNA, and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Aug 20, 2024·2 cites·6 claims
- 1483US12383589B2Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Granted Aug 12, 2025·0 cites·19 claims
- 1583US12338433B2Modified nucleic acids, hybrid guide RNAS, and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2023·Granted Jun 24, 2025·0 cites·3 claims
- 1681US11717548B2Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Aug 8, 2023·1 cites·22 claims
- 1780US2023124955A1Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
- 1878US10683379B2Polymers, hydrogels, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jun 16, 2020·2 cites·28 claims
- 1975US12029790B2Biomimetic nanomaterials and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Jul 9, 2024·1 cites·9 claims
- 2067US2025188140A1Ccl5 mrna nanoparticle and methods of use thereofOHIO STATE INNOVATION FOUNDATION·Filed 2023·Application pending·0 cites
- 2162US11845929B2Modified nucleic acids, hybrid guide RNAs, and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Dec 19, 2023·0 cites·4 claims
- 2262US2025041442A1Diamino lipid (dal) compounds and pharmaceutical compositions comprising an immunotherapeutic agentOHIO STATE INNOVATION FOUNDATION·Filed 2022·Application pending·0 cites
- 2355US2025135007A1Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereofWEISS RON·Filed 2022·Application pending·0 cites
- 2454US11622942B2Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Apr 11, 2023·0 cites·20 claims
- 2554US10457631B2Biodegradable amino-ester nanomaterials for nucleic acid deliveryOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Oct 29, 2019·0 cites·20 claims
- 2654US2025099392A1Compositions comprising lipid compounds and methods of making and use thereofOHIO STATE INNOVATION FOUNDATION·Filed 2023·Application pending·0 cites
- 2753US2011275707A1Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agentsLEE KUO-HSIUNG·Filed 2009·Application pending·0 cites
- 2853US2025032415A1Compositions comprising amino lipid compounds and methods of making and use thereofOHIO STATE INNOVATION FOUNDATION·Filed 2022·Application pending·0 cites
- 2953US2023000908A1Engineered cells and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2020·Application pending·0 cites
- 3052US2024254076A1Lipid nanomaterials and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2022·Application pending·0 cites
- 3150US12275951B2Engineered guide RNA and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Apr 15, 2025·0 cites·4 claims
- 3250US2024140960A1Sugar derived lipid nanomaterials and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2022·Application pending·0 cites
- 3348US2023303598A1Bioinspired lipid derivatives and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2021·Application pending·0 cites
- 3448US2022152085A1Combination immunoregulation and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2020·Application pending·0 cites
- 3547US2023181743A1Functional lipid derivatives and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2021·Application pending·0 cites
- 3644US2022162618A1Engineered mrna sequences and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2020·Application pending·0 cites
- 3741US10736966B2Brush-poly (glycoamidoamine)-lipids and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Aug 11, 2020·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Yizhou Dong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →